Share on Facebook
Share on Twitter
Share on LinkedIn

Four pharmacy benefit managers must face a lawsuit alleging they breached their duties as administrators of employee health insurance plans’ drug benefits by causing Mylan NV to raise the EpiPen allergy medication’s price, a federal judge has ruled.

U.S. District Judge Paul Magnuson in St. Paul, Minnesota on Friday denied motions by CVS Health Corp, Express Scripts Holdings, UnitedHealth Group Inc and Prime Therapeutics to dismiss a proposed class action by participants in employee health insurance plans.

Read More